Late immune recovery in children treated for malignant diseases

Pathology and Oncology Research

Volumn 14, Issue 4, 2008, Pages 391-397

  Kovacs, Gabor T ^a   Barany, Olga ^a   Schlick, Barbara ^a   Csoka, Monika ^a   Gado, Judit ^a   Ponyi, Andrea ^a   Müller, Judit ^a   Nemeth, Julia ^a   Hauser, Peter ^a   Erdelyi, Daniel J ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cellular immunity; Children; Humoral immunity; Late effects; Malignant diseases

Indexed keywords

ASPARAGINASE; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; TIOGUANINE; VINBLASTINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELLULAR IMMUNITY; CHILD; CHILDHOOD CANCER; CONVALESCENCE; EWING SARCOMA; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; SOLID TUMOR; T LYMPHOCYTE;

ANTIBODY FORMATION; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CELL PROLIFERATION; CHILD; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULINS; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; MALE; NEOPLASMS; T-LYMPHOCYTES;

EID: 60049083050     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9073-5     Document Type: Article

References (38)

1. Smith MA, Ries LAG (2002) Childhood cancer: Incidence, survival and mortality. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott Williams and Wilkins, Philadelphia, pp 1-12
2. Schrappe M (2004) Evolution of BFM trials for childhood ALL. Ann Hematol 83(suppl 1):S121-S123
3. Pinkerton R (2005) Continuing challenges in childhood non- Hodgkin lymphoma. Br J Haematol 130:480-488
4. Smith M, Hare ML (2004) An overview of progress in childhood cancer survival. J Pediatr Oncol Nursing 21:160-164
5. Ajiki W, Tsukuma H, Oshima A (2004) Survival rates of childhood cancer patients in Osaka, Japan. Jap J Clin Oncol 34:50-54
6. Lando A, Holm K, Nysom K et al (2001) Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin Endocrinol 55:21-25
7. Schwartz CL (1999) Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 4:45-54
8. Arguelles B, Barrios V, Pozo J et al (2000) Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia: a longitudinal study. J Clin End Met 85:4087-4092
9. Larson DL, Kroll S, Jaffe N et al (1990) Long-term effects of radiotherapy in childhood and adolescence. Am J Surg 160:348- 351
10. Cicognani A, Pasini A, Pession A et al (2003) Gonadal function and pubertal development after treatment of a childhood malignancy. J Ped End 16(Suppl 2):321-326
11. Harris J, Sengar D, Stewart T et al (1976) The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease. Cancer 37:1058-1069
12. Hektoen L, Corper HJ (1921) The effect of mustard gas (dichclorethylsulphid) on antibody formation. J Inf Dis 28:279- 285
13. Calabresi P, Chabner BA (1991) Antineoplastic agents. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman and Gilman's: the pharmacological basis of therapeutics. McGraw-Hill, Singapore, pp 1209-1263
14. Alanko S, Pelliniemi T, Salmi T (1994) Recovery of blood lymphocytes and serum immunoglobulins after treatment of solid tumors in children. Ped Hematol Oncol 11:33 - 45
15. Mustafa M, Buchanan G, Winick N et al (1998) Immune recovery in children with malignancy after cessation of chemotherapy. J Ped Hematol Oncol 20:451-457
16. Komada Y, Zhang SL, Zhou YW et al (1992) Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy. Cancer Immunol Immunther 35:271-276
17. Craenendonk E, van Gennip AH, Abeling NGM et al (1984) Numerical changes in the various peripheral white blood cells in children as a result of antineoplastic therapy. Acta Haematol 72:315-325
18. Mackall C, Fleisher T, Brown M et al (1995) Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143-149
19. Moritz B, Eder J, Meister B et al (2001) Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy. Med Ped Oncol 36:283-289
20. Smith S, Schiffman G, Karayalcin G et al (1995) Immunodeficiency in long-term surviors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster therapy. J Ped 127:68-75
21. Reinhardt D, Houliara K, Pekrun A et al (2003) Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancer. Scand J Inf Dis 35:851-857
22. Eckschlager T, Jira M, Strejcek J (1991) Cell-mediated immunity in children with Hodgkin s and non-Hodgkin s lymphomas. Ped Hematol Oncol 8:251-256
23. Gale RP, Butturini A (1991) Maintenance chemotherapy and cure of childhood acute lymphoblastic leukemia. Lancet 338:1315- 1318
24. Alanko S, Salmi TT, Pelliniemi TT (1995) Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Ped Oncol 24:373-378
25. Alanko S, Pelliniemi T, Salmi TT (1992) Recovery of blood B- lymphocytes and serum immunoglobulins after treatment for childhood acute lymphoblastic leukemia. Cancer 69:1481-1486
26. Yamada S, Komiyama A (1991) Decrease in number of CD16 (Leu 11)+CD45RA (2H4)+ cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia. Leukemia Res 15:785-790
27. Jackson SK, Parton J, Shortland G et al (1990) Serum immunoglobulins to endotoxin core glycolipid: acute leukaemia and other cancers. Arch Dis Child 7:771-773
28. Yabuhara A, Kawai H (1990) A recycling defect as a characteristic of natural killer cells in childhood acute lymphoblastic leukemia. Ped Res 28:572-578
29. Bahceci E, Epperson D, Douek DC et al (2003) Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism. Br J Haematol 122:934-943
30. Lynch BA, Vasef MA, Comito M et al (2003) Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation. Bone Marrow Transplant 32:527-533
31. Kalwak K, Moson I, Cwian J et al (2003) A prospective analysis of immune recovery in children following allogeneic transplantation of T-cell-depleted or non-T-cell-depleted hematopoietic cells from HLA-disparate family donors. Transplant Proc 35:1551 - 1555
32. Kalwak K, Gorczynska E, Toporski J et al (2002) Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 118:74-89
33. Auletta JJ, Fisher VL (2001) Immune reconstitution in pediatric stem-cell transplantation. Front Bioscience 6:G23-G32
34. Locatelli F, Maccario R, Comoli P et al (1996) Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. Bone Marrow Transplant 18:1095-1101
35. Oppemheim JJ (1975) Use of lymphocyte transformation to assess clinical disorders. In: Vyas GN, Stites DP, Brecher G (eds) Laboratory diagnosis of immunologic disorders. Grune and Stratton, New York, p 87
36. Benczúr M (1981) In vitro assay for detection of natural killer (NK) cells. In: Erdei A, Fésûs L, Rajnavölgyi É (eds) Immunological methods. Springer, Budapest, p 122
37. Coligan JE (1991) Current protocols in immunology. NIH, John Wiley Interscience, Boston, pp 181-183
38. Kristinsson VH, Kristinsson JR, Jonmundsson GK et al (2001) Immunoglobulin class and subclass concentrations after treatment of childhood leukemia. Ped Hematol Oncol 18:167-172 2001